TFRC-mediated immune exclusion as a therapeutic vulnerability in cervical cancer: A comprehensive analysis based on the cancer immunoediting process

Cancer Genetics · Published 2026-05-19 · DOI 10.1016/j.cancergen.2026.05.005

Authors (6)

Hong-Jian Ling, Jia-li Zhou, Lu-Qi Cao, Ryan Li, Zhe-Sheng Chen, Qiang Yi

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Ling, H., Zhou, J., Cao, L., et al. (2026). TFRC-mediated immune exclusion as a therapeutic vulnerability in cervical cancer: A comprehensive analysis based on the cancer immunoediting process. Cancer Genetics. https://doi.org/10.1016/j.cancergen.2026.05.005

Related articles

• Autophagy inhibition enhances PD-1 blockade efficacy in mismatch repair–proficient colorectal cancer · Cancer Genetics · 2026 · Same journal
• A decision-oriented framework for genomic testing across the prostate cancer continuum · Cancer Genetics · 2026 · Same journal
• Beyond ATRX: The heterogeneous basis of Alternative Lengthening of Telomeres in osteosarcoma · Cancer Genetics · 2026 · Same journal
• Genetic variations in base excision repair genes and the risk of developing hepatoblastoma: A five-center case-control study from East China · Cancer Genetics · 2026 · Same journal
• Persistent monosomy 7 in Philadelphia chromosome-negative cells without disease progression over nearly two decades of follow-up in chronic myeloid leukemia · Cancer Genetics · 2026 · Same journal
• Novel truncating WT1 germline variant in a case of familial Wilms tumor · Cancer Genetics · 2026 · Same journal
• Clinical utility and implementation of a virtual molecular tumor board in real-world oncology practice · Cancer Genetics · 2026 · Same journal
• Myeloid neoplasms with mutated KIT: comparative clinicopathologic analysis of D816 vs. non-D816 variants · Cancer Genetics · 2026 · Same journal
• Prohibitins in cancer: Multifaceted regulators of mitochondrial homeostasis, oncogenic signaling, tumor microenvironment, and therapeutic resistance · Cancer Genetics · 2026 · Same journal
• A de novo MEN1 gene mutation in a 4-year-old boy with hypoglycemia: A case report and functional study · Cancer Genetics · 2026 · Same journal